Nasdaq · CIK 0001551306
PGNY Progyny, Inc.
A
95 / 100
Material weaknesses
1
Restatements
0
Auditor changes
0
Late filings
0
Quarters with open weakness
1
Remediations
1
Deductions
20
Remediation credit
15
Trailing 24 months from 2024-11-07. Rubric v1. How this is scored.
Disclosures, in the company's words
“we and our independent registered public accounting firm identified one material weakness in our controls related to the lack of review and oversight of financial reporting, which we determined was remediated as of December 31, 2019.”
Remediation disclosed
- 10-Q · filed 2026-11-05 · source filing ↗
“in connection with our audit of the fiscal year 2018 consolidated financial statements, we and our independent registered public accounting firm identified one material weakness in our controls related to the lack of review and oversight of financial reporting, which we determined was remediated as of December 31, 2019.”
Filings read
- 10-Q · 2026-11-05read
- 10-Q · 2026-08-07queued
- 10-Q · 2026-05-08queued
- 10-K · 2026-02-27queued
- 10-Q · 2025-11-07queued
- 10-Q · 2025-08-08queued
- 10-Q · 2025-05-09queued
- 10-K · 2025-03-03queued
- 10-Q · 2024-11-12queued
Think something here is wrong? Request a correction. Open corrections hide the affected disclosure until resolved.